How many insider trades does FilingIQ track for HRT?

FilingIQ tracks 300 Form 4 insider transactions for HRT (ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/), covering filings from Jan 20, 2015 onwards. 0 of those were filed in the last 90 days.

Are HRT insiders net buyers or net sellers?

Across the full Form 4 history for HRT, 117 transactions (39%) were open-market purchases and 57 (19%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does HRT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is HRT in?

ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $634.

HRT insider trading

OTC Markets OTCPK Healthcare

ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

300

Last 90 days

Buys / sells

39% / 19%

Market cap

$634

About ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/

Micron Solutions, Inc. operates as a contract manufacturer for the medical device, defense, and life sciences markets. It offers precision machining, thermoplastic injection molding, mold making products; sensors; orthopedic implants and devices; and diagnostic test kits. The company provides solutions for medical, orthopedics, consumer, test kits, life sciences, consumer, defense, drug delivery devices, and automotive industries. Micron Solutions, Inc. was founded in 1978 and is based in Fitchburg, Massachusetts.

Company website: www.micronsolutions.com

HRT insider activity at a glance

FilingIQ has scored 300 insider transactions for HRT since Jan 20, 2015. The most recent filing in our index is dated Jun 28, 2024.

Across the full history, 117 open-market purchases and 57 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on HRT insider trades is 47.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live HRT trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for HRT?: FilingIQ tracks 300 Form 4 insider transactions for HRT (ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/), covering filings from Jan 20, 2015 onwards. 0 of those were filed in the last 90 days.
Are HRT insiders net buyers or net sellers?: Across the full Form 4 history for HRT, 117 transactions (39%) were open-market purchases and 57 (19%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does HRT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is HRT in?: ARRHYTHMIA RESEARCH TECHNOLOGY INC /DE/ (HRT) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $634.

Methodology & sources

Every HRT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.